NOTTO wants women prioritised in allocation of deceased donor organs
NEW DELHI: The National Organ and Tissue Transplant Organisation (NOTTO) has suggested prioritising women in allocation of deceased donor organs.
In a letter to the states/UTs, the apex authority for regulating organ donations and transplants in the country, has said a provision should be made to mark additional points for women recipients of donor organs, to address gender disparity.
Studies have shown that while women make up a large percentage of donors, they receive fewer organs than men. "Women are equally vulnerable when it comes to end-stage organ failure due to illness, and it is important that organs are available for conducting a transplant - either through a living donor or deceased donor - for them," NOTTO director Dr Anil Kumar told TOI recently.
NOTTO's letter sent on Aug 2, the eve of Organ Donation Day, called for additional measures like ensuring that deceased donors get a dignified funeral.
Many states have mandated that the district magistrate concerned, or another senior official attend the funeral. The NOTTO directive suggests prioritising relatives of a deceased donor in allocation of organs should they require it.
As per the annual report on organ donations in India in 2024-25, released on eve of Organ Donation Day, India carried out close to 19,000 organ transplants in 2024-25. Of these, 3,403 (17%) transplants were performed using organs retrieved from deceased donors or persons declared brain-dead.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
an hour ago
- Economic Times
Goa becomes India's first state to cut prices on high-cost cancer and rare disease therapies
Synopsis Goa government introduces a pioneering pricing policy for expensive treatments, including cancer and rare diseases, making it the first state in India to do so. This initiative allows the state to negotiate prices for drugs, medical equipment, and diagnostics, ensuring more patients can access critical care. ETHealthWorld In a bid to make life-saving therapies more accessible to patients, the Goa government has introduced a groundbreaking pricing policy for expensive treatments, including those for cancer and rare diseases, according to a TOI report. The initiative allows the state to procure drugs, medical equipment, and diagnostics at negotiated prices below the listed rates, enabling resources to reach a larger number of patients or extend the duration of therapies. Health Minister Vishwajit Rane announced on Wednesday that Goa is the first state in the country to implement such a policy framework, which facilitates confidential pricing agreements with pharmaceutical companies and medical device manufacturers. The rollout is expected to begin with treatments for lung cancer, a condition among several high-cost therapies that can exceed Rs 50 lakh per year. According to Rane, this initiative represents a significant step toward health equity, ensuring more patients can access critical care. 'Goa's adoption of this value-based pricing policy is both timely and essential,' Rane said. 'It will improve access to innovative therapies and help more patients benefit from these treatments.' Addressing the rising burden of diseases The report noted that Goa faces a growing healthcare challenge, with around 1,500 new cancer cases diagnosed annually, expected to rise by 5% each year. Breast cancer is the most common, accounting for over 300 cases, followed by oral cavity cancer, which makes up 20-25% of total cases. Rane highlighted the need for a more robust healthcare system to meet the increasing demand for specialized treatments and rare disease management. Policy framework & implementation The new pricing policy focuses on proprietary drugs and equipment already procured by the Goa Medical College (GMC) and the Directorate of Health Services (DHS) through standard tenders. If new patented drugs or devices are required, a committee will review the recommendation and seek approval from the finance department before inclusion. A committee led by the Additional/Joint Secretary of Health, along with the GMC dean, DHS director, and pharmacy heads, will determine appropriate pricing and negotiate with companies to secure the best rates for patented treatments. Once approved, the finalized list of drugs and equipment will be notified with finance department approval, TOI further reported. This move is expected to ease financial pressure on patients while equipping Goa's healthcare system to better handle the rising incidence of cancer and rare disorders, setting a precedent for other states to follow.
Time of India
an hour ago
- Time of India
Goa becomes India's first state to cut prices on high-cost cancer and rare disease therapies
In a bid to make life-saving therapies more accessible to patients, the Goa government has introduced a groundbreaking pricing policy for expensive treatments, including those for cancer and rare diseases, according to a TOI report. Independence Day 2025 Before Trump, British used tariffs to kill Indian textile Bank of Azad Hind: When Netaji gave India its own currency Swadeshi 2.0: India is no longer just a market, it's a maker The initiative allows the state to procure drugs, medical equipment, and diagnostics at negotiated prices below the listed rates, enabling resources to reach a larger number of patients or extend the duration of therapies. Health Minister Vishwajit Rane announced on Wednesday that Goa is the first state in the country to implement such a policy framework, which facilitates confidential pricing agreements with pharmaceutical companies and medical device manufacturers. The rollout is expected to begin with treatments for lung cancer, a condition among several high-cost therapies that can exceed Rs 50 lakh per year. According to Rane, this initiative represents a significant step toward health equity, ensuring more patients can access critical care. 'Goa's adoption of this value-based pricing policy is both timely and essential,' Rane said. 'It will improve access to innovative therapies and help more patients benefit from these treatments.' Live Events Addressing the rising burden of diseases The report noted that Goa faces a growing healthcare challenge, with around 1,500 new cancer cases diagnosed annually, expected to rise by 5% each year. Breast cancer is the most common, accounting for over 300 cases, followed by oral cavity cancer, which makes up 20-25% of total cases. Rane highlighted the need for a more robust healthcare system to meet the increasing demand for specialized treatments and rare disease management. Policy framework & implementation The new pricing policy focuses on proprietary drugs and equipment already procured by the Goa Medical College (GMC) and the Directorate of Health Services (DHS) through standard tenders. If new patented drugs or devices are required, a committee will review the recommendation and seek approval from the finance department before inclusion. A committee led by the Additional/Joint Secretary of Health, along with the GMC dean, DHS director, and pharmacy heads, will determine appropriate pricing and negotiate with companies to secure the best rates for patented treatments. Once approved, the finalized list of drugs and equipment will be notified with finance department approval, TOI further reported. This move is expected to ease financial pressure on patients while equipping Goa's healthcare system to better handle the rising incidence of cancer and rare disorders, setting a precedent for other states to follow.
Hans India
7 hours ago
- Hans India
People urged to donate organs
Vijayawada: The NSS Unit of Siddhartha Academy of Higher Education (Deemed to be University), here organised an organ donation awareness programme in collaboration with Manipal Hospital and Red FM on the occasion of Organ Donation Day on Wednesday. The programme was aimed to sensitise students, faculty, and staff about the vital role of organ donation in saving lives. Registrar Dr M Ravichand appreciated the noble cause of organ donation, noting that by pledging their organs, individuals can offer hope and grant a new lease of life to those in need. Dean of Admissions Dr GSN Swami highlighted the importance of accessible medical services and expressed his gratitude to Manipal Hospital for conducting such a meaningful awareness initiative. J Ramanjaneya Reddy, Director of Manipal Hospital noted that women are at the forefront of organ donation, setting an inspiring example for society. He also expressed appreciation to the Central Government for the Jeevandan programme and motivated students by stating that 'organ donation is a second chance to live.' Distinguished medical professionals from Manipal Hospital–-Dr Utham Sharma, Clinical Head; Dr Bathina Rajesh, Consultant Medical Gastroenterologist; Dr Hariprasad, Urologist & Renal Transplant Surgeon–along with A Mohan, AP Joint Transport Commissioner & NTR District In-charge Deputy Transport Commissioner, addressed the gathering. They explained the process, legal aspects, and life-changing impact of organ donation, sharing inspiring real-life stories of donors and recipients, and stressing the urgent need to bridge the gap between demand and availability of organs. Representatives from Red FM extended their support by engaging the audience with interactive sessions. Students, faculty members, and staff of Siddhartha Academy, pledged their commitment to supporting and promoting organ donation. The University authorities commended the University NSS Coordinator, Dr G Sivarama Prasad and Programme Officers Dr K Madhavi and Dr A Venugopal Reddy and the collaborative efforts of Manipal Hospital and Red FM for their dedication to this noble cause, reaffirming their commitment to hosting more socially impactful events in the future.
